High-performance passive coatings
for implanted medical devices

Nilbax^TM protects dental and orthopedic implant surfaces by reducing bacterial adhesion, biofilm formation, and infection- and inflammation-related risks

Nilbax™ is developed by TekCyte, an Australian surface-coating technology company addressing
complex fouling and contamination challenges across medical and industrial applications

A high-performance passive coating solution
addressing infection and inflammation

Nilbax™ targets distinct healthcare risks and costs associated with
dental and orthopedic implants

Nilbax™ for DENTAL implants

Nilbax™ for ORTHOPEDIC components

Our coating solutions are drug-free, non-leaching and hydrophilic – offering
long-lasting protection without releasing active substances into the body.

A breakthrough in biofilm prevention

Implant-related infections remain a persistent clinical and economic burden, contributing to post-operative complications, implant failure and revision surgery.

Nilbax^TM is a high-performance passive coating designed to create a protective surface barrier on medical implants, reducing bacterial adhesion and helping prevent persistent biofilm formation.

Nilbax^TM is targeted for dental implant and orthopedic component applications.

Developed by TekCyte, an Australian surface-coating technology company.

EXPLORE TEKCYTE’S BROADER COATING PLATFORM →

What Nilbax™ delivers

Reduces bacterial adhesion and biofilm formation
– decreasing infection and inflammation risk
Acts passively – no antibiotics, silver or active
biological agents
Chemically stable – commercially scalable
Suitable for several device materials including titanium
and stainless steel
Compatible with standard sterilisation methods
Patented and available for licensing

Flexible licensing and engagement models

We offer flexible engagement models to suit your product lifecycle and commercial goals:

Technology licensing – for Nilbax™

Proof-of-concept evaluations – for early testing and validation

Collaborative development – for custom or strategic projects

Fee-for-service coating – for fast, technical support during prototyping

Our staged approach is designed to reduce regulatory complexity and support confident integration.

Global collaborations with purpose

TekCyte works with leading innovators across medical, biotech and industrial sectors to bring advanced coating science into real-world application.

We have collaborated with organisations including Saint-Gobain, Cynata Therapeutics, Alyra Biotech and Osmoflow.

Using world-leading surface technologies, the TekCyte team contributes deep technical expertise and scientific insight to a wide range of commercial projects and research collaborations, supporting both early-stage innovation and commercial-scale integration.

These collaborations reflect our reputation for high-quality, flexibility and results-driven execution in addressing complex surface challenges.

See how our coatings perform in real-world applications.

Our collaborations

Using world-leading surface technologies, the TekCyte team contributes their extensive knowledge and know-how to a diverse range of commercial projects and research collaborations.

High-performance passive coatings for implanted medical devices

NilbaxTM protects dental and orthopedic implant surfaces by reducing bacterial adhesion, biofilm formation, and infection- and inflammation-related risks

Nilbax™ is developed by TekCyte, an Australian surface-coating technology company addressingcomplex fouling and contamination challenges across medical and industrial applications

A high-performance passive coating solutionaddressing infection and inflammation